missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ Human VEGF-165 Recombinant Protein, PeproTech®

Artikelnummer. 17809912
Ansicht ändern
Click to view available options
Menge:
1 mg
10 μg
100 μg
2 μg
250 μg
50 μg
500 μg
Packungsgröße:
1 Milligramm
10 Mikrogramm
100 Mikrogramm
2 Mikrogramm
250 Mikrogramm
50 Mikrogramm
500 Mikrogramm
7 product options available for selection
Product selection table with 7 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
17809912 50 μg 50 Mikrogramm
17821473 100 μg 100 Mikrogramm
17861763 10 μg 10 Mikrogramm
17800953 1 mg 1 Milligramm
17839922 250 μg 250 Mikrogramm
17819912 2 μg 2 Mikrogramm
17820873 500 μg 500 Mikrogramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 7 options available.
7 options
This item is not returnable. View return policy
Product Code. 17809912 Supplier Gibco™ Supplier No. 1002050UG
Folgen Sie dem Workflow - Entdecken Sie die Einsparungen
Verwenden Sie den Aktionscode 27967
View all promotions
 Eingeschränkter Artikel
Lager vorrätig
Add to basket
Edge
Add to basket

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

Recombinant Protein

Recombinant Human VEGF 165 is a 38.2 kDa, disulfide-linked homodimeric protein consisting of two 165 amino acid polypeptide chains. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis

The vascular endothelial growth factor (VEGF) family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receptor system have been shown to be the fundamental regulators in the cell signaling of angiogenesis. Most tumors have the absolute requirement of angiogenesis and VEGF has been described as the most potent angiogenic cytokine linked to this process. To date 5 different isoforms of VEGF have been described. These isoforms are generated as the result of alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine-kinase receptors flt-1 (VEGFR-1) and flk-1/KDR (VEGFR-2), which have been found to be expressed almost exclusively on endothelial cells.
TRUSTED_SUSTAINABILITY

Specifications

Zugriffsnummer P15692
Zur Verwendung mit (Anwendung) Control, Western Blot Control, Bioactivity
Zusammensetzung Protein with no preservative
Gen-ID (Entrez) 7422
Molekulargewicht 38.2 kDa
Name Human VEGF-165
Reinigungsverfahren Purified
Menge 50 μg
Quelle E. coli
Lagerungsbedingungen -20°C
Regulatorischer Status RUO
Endotoxin-Konzentration <1 EU/μg
Gen-Alias H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF
Gebräuchliche Bezeichnung VEGF-165
Gensymbol Vegfa
Biologische Aktivität Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml
Produkttyp Protein
Konjugat Unconjugated
Rekombinant Recombinant
Sequenz APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
Inhalt und Lagerung -20°C
Aktivität Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0ng/ml.
Expressionssystem E. coli
Form Lyophilized
Reinheits- oder Qualitätsgrad ≥ 98% by SDS-PAGE gel and HPLC analyses.
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.